2170 — Suzhou Basecare Medical Income Statement
0.000.00%
Last trade - 00:00- HK$555.26m
- HK$440.97m
- CNY233.27m
Annual income statement for Suzhou Basecare Medical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 107 | 141 | 208 | 299 | 233 |
| Cost of Revenue | |||||
| Gross Profit | 51.1 | 59.5 | 91.4 | 136 | 124 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 232 | 267 | 402 | 530 | 447 |
| Operating Profit | -124 | -126 | -194 | -231 | -214 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -126 | -127 | -196 | -240 | -227 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -144 | -133 | -193 | -237 | -223 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -144 | -123 | -192 | -237 | -223 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -144 | -123 | -192 | -237 | -223 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.541 | -0.482 | -0.701 | -0.867 | -0.817 |